Stock Symbol:

IMGN

Company Name:

ImmunoGen, Inc.

Company Description:

ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops therapeutics for the treatment of cancer using its Targeted Antibody Payload (TAP) technology, which uses antibodies to deliver a potent cytotoxic agent.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NASDAQ

Predicted Split Price:

$44.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

3.2%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.